---
schema_version: "secwatch.filing_event.v1"
accession: "0000012208-26-000024"
form_type: "8-K"
ticker: "BIO"
cik: "0000012208"
company_name: "BIO-RAD LABORATORIES, INC."
filed_at: "2026-04-24T23:59:59+00:00"
generated_at: "2026-05-15T04:10:32.928241+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Stockholders approve Amended 2017 Incentive Award Plan, adding 335,000 shares

## Summary
- Plan approved with 6.85M for, 105k against; extends expiration to March 18, 2036.
- Increases share reserve by 335,000 shares for future equity grants.
- Stockholder proposal on dual-class capital structure defeated (1.47M for, 5.46M against).
- All six director nominees elected; KPMG ratified as auditors for FY 2026.

## SEC filing metadata
- accession: 0000012208-26-000024
- form_type: 8-K
- ticker: BIO
- cik: 0000012208
- company_name: BIO-RAD LABORATORIES, INC.
- filed_at: 2026-04-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/12208/000001220826000024/0000012208-26-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/12208/000001220826000024/bio-20260421.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000012208-26-000024
- JSON: https://secwatch.observer/filing/0000012208-26-000024.json
- Plain text: https://secwatch.observer/filing/0000012208-26-000024.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.